ELVIS & ROSALYND

A problem of pharmaceutical contrast, solved through computational progress: ELVIS & ROSALYND — seeking the end of undruggable targets, fueled by AI and machine learning.

The Platforms page was designed with to tell the story of contrast between the current problem of pharmaceutical research and the solution that 1910 Genetics’ computational platforms offer.


As the page transitions into the solution section, the contrast continues, but switches pace, slowing the rhythm of progression and directing the user to the computational platforms’ interactive sections.



Once there, the dynamic visual narrative takes over, as the user is guided to interact with the dropdown menus; gaining further insights into the process and capabilities of ELVIS and ROSALYND (1910 Genetics’ AI and machine learningpowered computational platforms).

Case study: https://www.fiftyseven.co/case/1910-genetics